Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. Canada
  4. Toronto Stock Exchange
  5. Canopy Growth Corporation
  6. News
  7. Sector news
    WEED   CA1380351009

CANOPY GROWTH CORPORATION

(WEED)
  Report
Delayed Toronto Stock Exchange  -  12:42 2022-09-30 pm EDT
3.850 CAD   +0.79%
10:15aBarclays Adjusts Canopy Growth's Price Target to $2 from $3.50, Maintains Underweight Rating
MT
09/28Canopy Growth Corp : Regulation FD Disclosure, Other Events, Financial Statements and Exhibits (form 8-K)
AQ
09/28Sector Update: Consumer Discretionary Stocks Surging Wednesday
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Sector news Alternative Medicine
07:38aTasly Pharmaceutical Wins Nod For Clinical Trial of Psoriasis Drug
MT
08/30Tianjin Chase Sun Pharmaceutical Co.,Ltd Reports Earnings Results for the Half Year End..
CI
08/25Shijiazhuang Yiling Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year..
CI
08/25Shandong Buchang Pharmaceuticals Co., Ltd. Reports Earnings Results for the Half Year E..
CI
08/23UBS Adjusts Dong-E E-Jiao's Price Target to 40.75 Yuan From 39.30 Yuan, Keeps at Neutra..
MT
08/19Dong-E-E-Jiao Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022
CI
08/19Tasly Pharmaceutical Group Co., Ltd Reports Earnings Results for the Half Year Ended Ju..
CI
08/19Tasly Pharmaceutical Group Scraps Plan to Spin Off BioPharm Unit for Listing
CI
08/17Dong-E-E-Jiao Co.,Ltd. Announces Cash Dividend for the Year 2021, Payable on August 23,..
CI
08/10Changrui Biotechnology Co., Ltd. announced that it expects to receive CNY 64 million in..
CI
07/25Shandong Dongxin Investment Co., Ltd. announced that it expects to receive CNY 180 mill..
CI
07/14Dong-E-E-Jiao Co.,Ltd. Provides Earnings Guidance for the Six Months Ended 30 June 2022
CI
07/12Shijiazhuang Yiling Pharmaceutical Co., Ltd. Announces Final Dividend on Share A for 20..
CI
07/12Transcript : Mauna Kea Technologies SA, Tasly Pharmaceutical Group Co., Ltd -..
CI
07/11Tasly Pharmaceuticals and Mauna Kea Technologies Announce Joint Venture and Licensing A..
CI
06/30Dong-E-E-Jiao Co.,Ltd. Approves Cash Dividend for the Year 2021
CI
05/27Shijiazhuang Yiling Pharmaceutical Co., Ltd. Approves Cash Dividend for 2021
CI
05/12Tianjin Chase Sun Pharmaceutical Co.,Ltd Announces Final Cash Dividend on A Shares for ..
CI
05/02Yiling Pharmaceutical's Q1 Profit Tumbles 28% as Sales Plummet
MT
04/29Shijiazhuang Yiling Pharmaceutical Co., Ltd. Proposes Final Cash Dividend for the Year ..
CI
04/28Dong-E-E-Jiao's Profit, Revenue Rise in Q1; Shares Jump 5%
MT
04/28Dong-E-E-Jiao Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2..
CI
04/28Tianjin Chase Sun Pharmaceutical Co.,Ltd Reports Earnings Results for the First Quarter..
CI
04/28Shijiazhuang Yiling Pharmaceutical Co., Ltd. Reports Earnings Results for the First Qua..
CI
04/27Shandong Buchang Pharmaceuticals Co., Ltd. Reports Earnings Results for the First Quart..
CI
04/25Tasly Pharmaceutical Group Co., Ltd Reports Earnings Results for the First Quarter Ende..
CI
04/22Tianjin Chase Sun Pharmaceutical Co.,Ltd Approves Profit Distribution Proposal for 2021
CI
04/18Yiling Pharma's Shares Sink on Doubts Over COVID-19 Drug Efficacy
MT
04/18Dong-E-E-Jiao Co.,Ltd. Provides Earnings Guidance for the Three Months Ended 31 March 2..
CI
03/31Tianjin Chase Sun Pharmaceutical Co.,Ltd Proposes Cash Dividend for 2021
CI
03/30Tasly Pharmaceutical Group Co., Ltd Reports Earnings Results for the Full Year Ended De..
CI
03/29UBS Adjusts Dong-E-E-Jiao's Price Target to 39.3 Yuan From 37.5 Yuan, Keeps at Neutral
MT
03/27Dong-E-E-Jiao Co.,Ltd. Proposes Cash Dividend as of 31 December 2021
CI
03/25Dong-E-E-Jiao Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 20..
CI
02/27Tianjin Chase Sun Pharmaceutical Co.,Ltd Reports Earnings Results for the Full Year End..
CI
01/27Dong-E-E-Jiao Expects Higher Profit in 2021
MT
01/27Dong-E-E-Jiao Co.,Ltd. Provides Earnings Guidance for the Year Ended December 31, 2021
CI
01/05Tranche Update on Tasly Pharmaceutical Group Co., Ltd's Equity Buyback Plan announced o..
CI
2021Sichuan Tianrunyuan Enterprise Management Co., Ltd., Pu Xiaoping, Wang Baocai, Li Weiju..
CI
2021Shunten International Limited Enters into Cooperation Framework Agreement with Shijiazh..
CI
2021Dong-E-E-Jiao Swings to Profit in January-September
MT
2021Dong-E-E-Jiao Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30,..
CI
2021Tianjin Chase Sun Pharmaceutical Co.,Ltd Reports Earnings Results for the Nine Months E..
CI
2021Shandong Buchang Pharmaceuticals Co., Ltd. Reports Earnings Results for the Nine Months..
CI
2021Tasly Pharmaceutical Group Co., Ltd Reports Earnings Results for the Nine Months Ended ..
CI
2021Shandong Buchang Pharmaceuticals Co., Ltd. and Shandong Buchang Shenzhou Pharmaceutical..
CI
2021Dong E E Jiao : Forecasts Up to 164% Surge in Q3 Profit
MT
2021Tranche Update on Tasly Pharmaceutical Group Co., Ltd's Equity Buyback Plan announced o..
CI
2021Shijiazhuang Yiling Pharmaceutical Co., Ltd. announced a financing transaction
CI
2021Sichuan Tianrunyuan Enterprise Management Co., Ltd., Pu Xiaoping, Wang Baocai, Li Weiju..
CI
2021Shandong Buchang Pharmaceuticals Co., Ltd. Reports Earnings Results for the Half Year E..
CI
2021Tianjin Chase Sun Pharmaceutical Co.,Ltd Reports Earnings Results for the Half Year End..
CI
2021Shijiazhuang Yiling Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year..
CI
2021Tasly Pharmaceutical Group Co., Ltd Reports Earnings Results for the Half Year Ended Ju..
CI
2021Dong-E-E-Jiao Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021
CI
2021Dong-E-E-Jiao Co.,Ltd. Announces Cash Dividend for the Year 2020, Payable on August 20,..
CI
2021HS Bio Sdn. Bhd. Enters into MOU with Shijiazhuang Yiling Pharmaceutical Co., Ltd
CI
2021Tranche Update on Tasly Pharmaceutical Group Co., Ltd's Equity Buyback Plan announced o..
CI
2021Shijiazhuang Yiling Pharmaceutical Co., Ltd. Announces 2020 Final Distribution Plan to ..
CI
2021Dong-E-E-Jiao Co.,Ltd. Announces Management Elections
CI
2021Dong-E-E-Jiao Co.,Ltd. Approves 2020 Profit Distribution Plan At the Annual General Mee..
CI
2021Tasly Pharmaceutical Group Co., Ltd commences an Equity Buyback Plan, under the authori..
CI
2021Tianjin Chase Sun Pharmaceutical Co.,Ltd Announces Final Dividend on A Shares for the Y..
CI
2021Tianjin Chase Sun Pharmaceutical Co.,Ltd Approves Cash Dividend for 2020
CI
2021Shijiazhuang Yiling Pharmaceutical Co., Ltd. Approves Dividend for the Year 2020
CI
2021Dong-E-E-Jiao Co.,Ltd. Reports Earnings Results for the First quarter Ended March 31, 2..
CI
2021Shijiazhuang Yiling Pharmaceutical Co., Ltd. Reports Earnings Results for the First Qua..
CI
2021Shandong Buchang Pharmaceuticals Co., Ltd. Reports Earnings Results for the First Quart..
CI
2021Tianjin Chase Sun Pharmaceutical Co.,Ltd Reports Earnings Results for the First Quarter..
CI
2021Tasly Pharmaceutical Group Co., Ltd Reports Earnings Results for the First Quarter Ende..
CI
2021Tasly Pharmaceutical Group Co., Ltd's Equity Buyback announced on April 25, 2020, has e..
CI
2021Shijiazhuang Yiling Pharmaceutical Co., Ltd. Proposes Final Cash Dividend for 2020
CI
2021Shijiazhuang Yiling Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year..
CI
2021Tianjin Chase Sun Pharmaceutical Co.,Ltd Announces Profit Distribution Proposal for 202..
CI
2021Tianjin Chase Sun Pharmaceutical Co.,Ltd Reports Earnings Results for the Full Year End..
CI
2021Dong-E-E-Jiao Co.,Ltd. Announces the Profit Distribution Proposal for 2020
CI
2021Dong-E-E-Jiao Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 20..
CI
2021Yiling Pharmaceutical Receives Approval for Lianhua Qingwen Capsules from The Pharmacy ..
CI
2021Dong-E-E-Jiao Co.,Ltd. Provides Earnings Guidance for the Year Ended 31 December 2020
CI
2021Tianjin Chase Sun Pharmaceutical Co.,Ltd cancelled the acquisition of additional 25% st..
CI
2021Yiling Pharmaceutical Provides Earnings Guidance for 2020
CI
2021Tranche Update on Tasly Pharmaceutical Group Co., Ltd's Equity Buyback Plan announced o..
CI
2020Yiling Pharmaceutical Announces Lianhua Qingwen Capsules Obtained Approval in the Phili..
CI
2020Tianjin Chase Sun Pharmaceutical Co.,Ltd Announces the Election of Li Li as an Independ..
CI
2020Yiling Pharmaceutical Receives Certificate of Registration for Dietary Supplements
CI
2020HS Bio Supplies Sdn Bhd Announces Memorandum of Understanding with Shijiazhuang Yiling ..
CI
2020Dong-E-E-Jiao Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30,..
CI
2020Tianjin Chase Sun Pharmaceutical Co.,Ltd Reports Earnings Results for the Nine Months E..
CI
2020Tasly Pharmaceutical Group Co., Ltd Reports Earnings Results for the Nine Months Ended ..
CI
2020Shandong Buchang Pharmaceuticals Co., Ltd. Reports Earnings Results for the Nine Months..
CI
2020Shijiazhuang Yiling Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Mont..
CI
2020Tranche Update on Tasly Pharmaceutical Group Co., Ltd's Equity Buyback Plan announced o..
CI
2020Tianjin Chase Sun Pharmaceutical Co.,Ltd(XSEC:30002..
CI
2020Preparation Products of Yiling Pharmaceutical Co., Ltd. Approves by FDA for Launch in t..
CI
2020Yiling Pharmaceutical's Lianhua Qingwen Receives First International Approval for COVID..
CI
2020Yiling Pharmaceutical Receives First International Approval for COVID-19 Treatment from..
CI
2020Shijiazhuang Yiling Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year..
CI
2020Shandong Buchang Pharmaceuticals Co., Ltd. Reports Earnings Results for the Half Year E..
CI
2020Dong-E-E-Jiao Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2020
CI
2020Tasly Pharmaceutical Group Co., Ltd Reports Earnings Results for the Half Year Ended Ju..
CI
Upcoming event on CANOPY GROWTH CORPORATION